GH
CLVS

GAM Holding’s Clovis Oncology, Inc. CLVS Stock Holding History

GAM Holding’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14,400
Closed -$655K – 994
2018
Q2 		$655K Sell
14,400
-7,400
-34% -$360K 0.02% 590
2018
Q1 		$1.15M Hold
21,800
– – 0.04% 412
2017
Q4 		$1.48M Hold
21,800
– – 0.05% 466
2017
Q3 		$1.8M Hold
21,800
– – 0.08% 276
2017
Q2 		$2.04M Hold
21,800
– – 0.03% 496
2017
Q1 		$1.39M Buy
+21,800
New +$1.33M 0.02% 585

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GAM Holding's CLVS Position: Q3 2018 in Review

GAM Holding sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 14,400 shares — an estimated $655K sold.

GAM Holding first reported a position in CLVS in Q1 2017 and held it in 6 quarters. The position peaked at $2.04M in Q2 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

  • GAM Holding reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
  • GAM Holding sold 14,400 Clovis Oncology, Inc. shares in Q3 2018, an estimated $655K.
  • GAM Holding first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 6 quarters.
  • GAM Holding's Clovis Oncology, Inc. position peaked at $2.04M in Q2 2017.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on GAM Holding's 13F filing for Q3 2018, filed 13 Nov 2018.